Ellen L. Barlow

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer.

Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer.

Journal: Therapeutic advances in medical oncology

Published: May 25, 2025

Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients.

Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients.

Journal: Bioengineering & translational medicine

Published: October 21, 2024

Conservative Management of Vulvar Cancer-Where Should We Draw the Line?

Conservative Management of Vulvar Cancer-Where Should We Draw the Line?

Journal: Cancers

Published: July 09, 2024

Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach.

Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach.

Journal: Advanced biology

Published: January 19, 2024

Groin Surveillance by Serial Ultrasonography Rather Than Sentinel Node Biopsy or Inguinofemoral Lymphadenectomy for Patients with Vulvar Cancer: A Pilot Study.

Groin Surveillance by Serial Ultrasonography Rather Than Sentinel Node Biopsy or Inguinofemoral Lymphadenectomy for Patients with Vulvar Cancer: A Pilot Study.

Journal: Cancers

Published: December 30, 2022

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Journal: Cancer

Published: June 17, 2022

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 24, 2022

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: September 13, 2021

Medial Inguino-Femoral Lymphadenectomy for Vulvar Cancer: An Approach to Decrease Lymphedema without Compromising Survival.

Medial Inguino-Femoral Lymphadenectomy for Vulvar Cancer: An Approach to Decrease Lymphedema without Compromising Survival.

Journal: Cancers

Published: August 25, 2021

The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: A Retrospective Australian Study.

The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: A Retrospective Australian Study.

Journal: Cancers

Published: September 30, 2020

Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis.

Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis.

Journal: Gynecologic oncology

Published: August 24, 2020

The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva.

The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva.

Journal: Journal of oncology

Published: September 17, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026